Go Pro
→ PH: Do THESE 4 things to your bank account now … (From Weiss Ratings) (Ad)tc pixel Free ABOS Stock Alerts

Acumen Pharmaceuticals (ABOS) Institutional Ownership

Acumen Pharmaceuticals logo
$2.73 +0.16 (+6.23%)
Closing price 07/8/2026 04:00 PM Eastern
Extended Trading
$2.70 -0.03 (-1.17%)
As of 07/8/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Acumen Pharmaceuticals (NASDAQ:ABOS)

Current
Institutional Ownership
Percentage
71.01%
Number of
Institutional Buyers
(last 12 months)
23
Total
Institutional Inflows
(last 12 months)
$6.87M
Number of
Institutional Sellers
(last 12 months)
16
Total
Institutional Outflows
(last 12 months)
$5.60M
Get ABOS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acumen Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ABOS Institutional Buying and Selling by Quarter

Acumen Pharmaceuticals Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026Bank of America Corp DE320,216$756K0.0%+33.3%0.443%
5/18/2026ADAR1 Capital Management LLC2,156,334$5.09M0.3%+142.0%2.985%
5/15/2026Rangeley Capital LLC35,000$83K0.1%N/A0.048%
5/15/2026OMERS ADMINISTRATION Corp28,600$67K0.0%+27.4%0.040%
5/14/2026Renaissance Technologies LLC473,946$1.12M0.0%+12.0%0.656%
5/14/2026Sei Investments Co.11,564$27K0.0%N/A0.016%
5/7/2026Dimensional Fund Advisors LP119,756$282K0.0%+144.1%0.166%
4/27/2026PFG Investments LLC80,850$191K0.0%+325.5%0.112%
4/16/2026SG Americas Securities LLC719,257$1.70M0.0%+79.3%0.996%
2/18/2026XTX Topco Ltd49,563$105K0.0%N/A0.082%
2/18/2026Ikarian Capital LLC254,312$537K0.0%-4.3%0.420%
2/18/2026Quadrature Capital Ltd49,046$103K0.0%N/A0.081%
2/18/2026Millennium Management LLC584,143$1.23M0.0%-2.9%0.964%
2/18/2026Boothbay Fund Management LLC39,585$84K0.0%-22.4%0.065%
2/18/2026Bridgeway Capital Management LLC170,171$359K0.0%-10.5%0.281%
2/16/2026OMERS ADMINISTRATION Corp22,454$47K0.0%N/A0.037%
2/13/2026Marshall Wace LLP20,907$44K0.0%N/A0.035%
2/13/2026State Street Corp100,178$211K0.0%-6.1%0.165%
2/12/2026Jane Street Group LLC142,123$300K0.0%-31.4%0.235%
2/12/2026Renaissance Technologies LLC423,100$893K0.0%-27.6%0.699%
2/12/2026Dimensional Fund Advisors LP49,062$104K0.0%+12.7%0.081%
2/10/2026Goldman Sachs Group Inc.117,851$249K0.0%-19.9%0.195%
2/9/2026Geode Capital Management LLC410,206$866K0.0%+2.9%0.677%
2/9/2026Prospera Financial Services Inc50,000$106K0.0%N/A0.083%
2/4/2026Independent Advisor Alliance19,000$40K0.0%N/A0.031%
1/26/2026PFG Investments LLC19,000$40K0.0%+65.2%0.031%
12/15/2025Hudson Bay Capital Management LP725,004$1.24M0.0%-12.1%1.197%
11/17/2025Jacobs Levy Equity Management Inc.16,001$27K0.0%N/A0.026%
11/17/2025Susquehanna International Group LLP214,440$367K0.0%+26.5%0.354%
11/17/2025Qube Research & Technologies Ltd32,881$56K0.0%-42.9%0.054%
11/17/2025Millennium Management LLC601,716$1.03M0.0%-69.1%0.993%
11/17/2025Bank of America Corp DE213,729$365K0.0%+45.4%0.353%
11/14/2025ADAR1 Capital Management LLC891,183$1.52M0.1%-2.7%1.471%
11/14/2025Bridgeway Capital Management LLC190,171$325K0.0%+65.1%0.314%
11/13/2025Pathstone Holdings LLC859,110$1.47M0.0%-18.8%1.418%
11/13/2025Franklin Resources Inc.2,305,096$3.94M0.0%-25.1%3.806%
11/7/2025Vanguard Group Inc.1,651,472$2.82M0.0%-2.2%2.727%
10/23/2025SG Americas Securities LLC403,878$691K0.0%N/A0.667%
8/19/2025Marex Group plc33,300$39K0.0%N/A0.055%
8/18/2025Hudson Bay Capital Management LP825,004$957K0.0%+7.1%1.362%
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
8/15/2025Hudson Bay Capital Management LP825,004$957K0.0%+7.1%1.362%
8/15/2025Bank of America Corp DE147,009$171K0.0%-7.5%0.243%
8/14/2025Jane Street Group LLC175,670$204K0.0%+1,526.0%0.290%
8/14/2025Qube Research & Technologies Ltd57,559$67K0.0%+160.0%0.095%
8/13/2025Marshall Wace LLP137,943$160K0.0%N/A0.228%
8/12/2025Franklin Resources Inc.3,077,039$3.57M0.0%-2.1%5.080%
8/8/2025Geode Capital Management LLC396,626$460K0.0%-54.0%0.655%
8/1/2025Y Intercept Hong Kong Ltd250,848$291K0.0%N/A0.414%
6/27/2025Goldman Sachs Group Inc.196,207$216K0.0%-10.5%0.324%
5/16/2025Goldman Sachs Group Inc.196,207$216K0.0%-10.5%0.324%
5/16/2025AQR Capital Management LLC41,735$46K0.0%N/A0.069%
5/16/2025ADAR1 Capital Management LLC146,183$161K0.0%+55.0%0.241%
5/12/2025Nuveen LLC78,446$86K0.0%N/A0.130%
5/12/2025Invesco Ltd.127,798$141K0.0%+544.1%0.211%
2/17/2025Two Sigma Investments LP301,268$518K0.0%-2.7%0.501%
2/17/2025Two Sigma Advisers LP499,100$858K0.0%+6.4%0.831%
2/17/2025Millennium Management LLC1,344,745$2.31M0.0%-26.7%2.238%
2/17/2025Deutsche Bank AG96,995$167K0.0%+468.7%0.161%
2/17/2025Bank of America Corp DE148,668$256K0.0%+7.2%0.247%
2/14/2025Jane Street Group LLC30,740$53K0.0%-116.1%0.051%
2/14/2025Susquehanna Fundamental Investments LLC14,731$25K0.0%N/A0.025%
2/14/2025Rock Springs Capital Management LP1,838,916$3.16M0.1%-20.0%3.061%
2/14/2025Tower Research Capital LLC TRC20,624$35K0.0%+427.5%0.034%
2/14/2025Dimensional Fund Advisors LP98,016$169K0.0%+73.3%0.163%
2/13/2025Barclays PLC93,082$161K0.0%+50.1%0.155%
2/13/2025Renaissance Technologies LLC257,213$442K0.0%-16.0%0.428%
2/13/2025ADAR1 Capital Management LLC94,294$162K0.0%N/A0.157%
2/12/2025Franklin Resources Inc.3,273,633$5.63M0.0%-7.8%5.449%
2/12/2025JPMorgan Chase & Co.937,908$1.61M0.0%+1,387.2%1.561%
2/11/2025Clune & Associates LTD.16,500$28K0.0%N/A0.027%
2/11/2025Intech Investment Management LLC18,847$32K0.0%N/A0.031%
2/6/2025Charles Schwab Investment Management Inc.126,747$218K0.0%+16.6%0.211%
1/30/2025Rhumbline Advisers53,076$91K0.0%-40.0%0.088%
1/17/2025SG Americas Securities LLC25,631$44K0.0%+44.2%0.043%
12/26/2024JPMorgan Chase & Co.63,066$156K0.0%+252.8%0.105%
11/27/2024Franklin Resources Inc.3,549,069$8.34M0.0%+5.4%5.907%
11/19/2024Barclays PLC61,997$154K0.0%+189.1%0.103%
11/16/2024Geode Capital Management LLC864,528$2.14M0.0%+6.5%1.439%
11/15/2024Barclays PLC61,997$154K0.0%+189.1%0.103%
11/15/2024State Street Corp516,406$1.28M0.0%+18.3%0.860%
11/13/2024FMR LLC2,028,117$5.03M0.0%+0.3%3.376%
11/13/2024The Manufacturers Life Insurance Company52,333$130K0.0%-12.8%0.087%
10/3/2024SG Americas Securities LLC17,772$44K0.0%N/A0.030%
8/16/2024Murchinson Ltd.56,250$136K0.0%N/A0.094%
8/15/2024Millennium Management LLC1,954,085$4.73M0.0%-25.7%3.252%
8/14/2024Murchinson Ltd.56,250$136K0.0%N/A0.094%
8/12/2024Marathon Trading Investment Management LLC26,298$64K0.0%-56.2%0.044%
8/9/2024Renaissance Technologies LLC338,100$818K0.0%N/A0.563%
8/9/2024Dimensional Fund Advisors LP56,548$137K0.0%-8.4%0.094%
8/8/2024American Century Companies Inc.45,444$110K0.0%+31.3%0.076%
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
8/1/2024Rhumbline Advisers52,323$127K0.0%N/A0.087%
7/26/2024Bank of New York Mellon Corp126,422$306K0.0%N/A0.210%
7/19/2024Gladius Capital Management LP10,939$26K0.0%N/A0.018%
5/17/2024Ikarian Capital LLC266,435$1.08M0.1%-15.5%0.443%
5/15/2024Price T Rowe Associates Inc. MD1,098,276$4.45M0.0%N/A1.828%
5/10/2024Vanguard Group Inc.1,665,058$6.74M0.0%-9.5%2.771%
5/7/2024Susquehanna Fundamental Investments LLC62,518$253K0.0%N/A0.104%
5/7/2024SG Americas Securities LLC12,856$52K0.0%N/A0.021%
2/23/2024Chicago Partners Investment Group LLC18,315$70K0.0%+34.9%0.032%
2/15/2024Parkman Healthcare Partners LLC603,497$2.32M0.3%+20.7%1.042%


ABOS Institutional Ownership - Frequently Asked Questions

During the previous two years, 53 institutional investors and hedge funds held shares of Acumen Pharmaceuticals. The most heavily invested institutionals were ADAR1 Capital Management LLC ($5.09M), FMR LLC ($5.03M), Franklin Resources Inc. ($3.94M), Rock Springs Capital Management LP ($3.16M), Vanguard Group Inc. ($2.82M), SG Americas Securities LLC ($1.70M), and JPMorgan Chase & Co. ($1.61M).Learn more on Acumen Pharmaceuticals' institutional investors.

71.01% of Acumen Pharmaceuticals' stock is owned by institutional investors. Learn more on ABOS's institutional investor holdings.

Of the 43 institutional investors that purchased Acumen Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: ADAR1 Capital Management LLC ($1.41M), JPMorgan Chase & Co. ($920.03K), SG Americas Securities LLC ($747.72K), Renaissance Technologies LLC ($388.95K), Jane Street Group LLC ($386.01K), Y Intercept Hong Kong Ltd ($250.85K), and Franklin Resources Inc. ($181.45K).

Institutional investors have bought a total of 3,473,851 shares in the last 24 months. This purchase volume represents approximately $6.87M in transactions.

Of the 16 institutional investors that sold Acumen Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($1.37M), Franklin Resources Inc. ($836.84K), Geode Capital Management LLC ($465.27K), Pathstone Holdings LLC ($199.42K), Renaissance Technologies LLC ($161.19K), Hudson Bay Capital Management LP ($100K), and Jane Street Group LLC ($65.12K).

Institutional investors have sold a total of 3,372,015 shares in the last 24 months. This volume of shares sold represents approximately $5.60M in transactions.


Related Companies

This page (NASDAQ:ABOS) was last updated on 7/9/2026 by MarketBeat.com Staff.
From Our Partners
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel